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Backgound
The use of Saccharomyces cerevisiae as a host system has
been limited by the perception of limited secretion capac-
ity, unstable episomal vectors and aberrant glycosylation.
Solutions to all of these limitations are now available.
Results
An analysis of a series of haploid laboratory yeast strains
revealed significant intra-strain variability and unstable
plasmid segregation. By combining classic chemical
mutagenesis and selection a family of highly efficient Sac-
charomyces cerevisiae strains has been developed for the
commercial production of biopharmaceutical products.
When combined with a stable [1], high copy number [2],
episomal expression vector system and a strong constitu-
tive promoter, secreted recombinant protein expression
titres in excess of 4 g/L were achieved (see Figure 1). Spe-
cific genetic modifications to the host were also intro-
duced to increase product yield and control post-
translational modifications, such as proteolysis and glyc-
osylation.
The expression vectors have been further enhanced to
facilitate the stable co-expression of multiple proteins.
When one of these proteins is a chaperone, the titre of co-
expressed recombinant transferrin was increased 15-fold.
The applicability of this system has been demonstrated
with a wide range of heterologous proteins and is scalable
from 10 mL shake flask to cGMP manufacture at high cell
density fermentation (8,000 L) in a defined synthetic
medium; designed to be integrated with cost-efficient
downstream processing.
Conclusion
Significant intra-strain variability and unstable episomal
plasmid systems have limited the usefulness of Saccharo-
myces cerevisiae as an industrial host for the production of
biopharmaceuticals. However co-enhancement of the epi-
somal vector system and the host strains is not only pos-
sible but has led to significant improvements in
recombinant protein production.
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Enhancement of protein production through chemical mutagenesis and specific gene disruptionsFigure 1
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